Skip to content

Coign Capital Advisors LLC: CGGR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Coign Capital Advisors LLC on CGGR, newest first. How the timeline and the estimate are built.

Coign Capital Advisors LLC held 252,969 CGGR shares at 2026-06-30 per its 13F-HR filed 2026-07-29.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 252,969 shares
    Change vs previous 13F +5,390 shares

    5.37% of the 13F portfolio, value $11,940,321.

    13F-HR 0001172661-26-002922 filed by Coign Capital Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 247,579 shares
    Change vs previous 13F +13,077 shares

    5.23% of the 13F portfolio, value $9,950,200.

    13F-HR 0001172661-26-001998 filed by Coign Capital Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 234,502 shares
    Change vs previous 13F +9,181 shares

    5.46% of the 13F portfolio, value $10,428,304.

    13F-HR 0001172661-26-000222 filed by Coign Capital Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 225,321 shares
    Change vs previous 13F -3,265 shares

    5.45% of the 13F portfolio, value $9,896,098.

    13F-HR 0001172661-25-004515 filed by Coign Capital Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 228,586 shares
    Change vs previous 13F not available

    6.29% of the 13F portfolio, value $9,292,021.

    13F-HR 0001172661-25-002858 filed by Coign Capital Advisors LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).